InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
-1.03%
)
Bitcoin
62,952.88
(
6.48%
)
Post# of 5675
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JellyDonut

Send PM Follow Ignore
Followers 61
Posts 7855
Boards Moderated 0
Alias Born 12/07/2007

JellyDonut

Re: None

Friday, 08/21/2015 10:23:26 AM

Friday, August 21, 2015 10:23:26 AM

Post# of 5675
Wall Street Journal Article:

http://www.wsj.com/articles/for-a-rare-disease-drug-trials-scramble-for-patients-1440013683

It mentions CTDH competitors. I think the main one is Vtesse. It appears they are behind CTDH in credibility as they are not even sure if their drug will work. The big difference IMO is that CTDH has compassionate drug status. Trappsol is being used and is working. Vtesse's drug is not. The 1 million dollars worth of Trappsol being given to needy families is generous but is also a great business move. Vtesse is also a brand new company, CTDH has been around for years, has made many connections, a definite advantage.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CYTH News
More CYTH News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!